-- With significant changes to Medicare quickly approaching, beneficiaries may face potential cost increases and benefit adjustments. Kure Care, Kenton Gray, and Dr. Krikor Tatoyan are introducing a solution to help individuals maintain access to advanced treatments. This initiative is intended to offer stability for patients before and during a period of healthcare system changes.
More information is available at https://curewounds.com.
Beneficiaries are projected to face notable financial challenges. The Centers for Medicare & Medicaid Services (CMS) has announced sweeping changes to wound care policies, with the most significant reforms taking effect January 1, 2026. These changes represent the most substantial overhaul of Medicare wound care reimbursement in years, driven by explosive spending growth and fraud concerns.
In addition to cost increases, specific benefits for the chronically ill will be affected. Starting in 2026, Medicare Advantage plans will have new restrictions on Special Supplemental Benefits for the Chronically Ill. These changes create uncertainty for individuals who depend on these programs for health management and highlight a need for reliable specialized care.
The changes have not been finalized but the proposed changes may cause confusion and difficulty for individuals to get crucial medical care in a timely matter after the first of the year.
Patients suffering from for non-healing wounds should seek treatment now before rules and benefits are changed.
"8.2 million Americans are suffering from chronic wounds while Medicare already covers the cure. That's not just a market failure - it's a moral failure," states Kent Gray, CEO. "KureCare exists to bridge that gap."
Kure Care offers a direct answer to these challenges with its specialized services. The organization provides advanced wound healing solutions, including regenerative medicine therapies. These treatments address complex conditions and are covered under existing federal health plan benefits, providing a stable option for care.
Kure Care is unique in the biologic wound care space making advanced regenerative wound care accessible to all with Medicare-covered amniotic grafts.
To address financial concerns, Kure Care reports high coverage rates. The company states that currently 95% of its qualified patients receive full coverage from their federal health programs for regenerative wound care treatments. This approval rate helps make advanced therapies financially accessible, removing a barrier for those needing consistent medical attention.
In addition to affordability, the treatments are clinically effective. Kure Care reports its advanced solutions can heal wounds 90% faster than some traditional methods. This accelerated healing process is a significant advantage for individuals with chronic conditions and can lead to an improved quality of life.
Access to these treatments is available through a broad operational footprint. Kure Care maintains a nationwide network of providers to deliver its services across the country.
Dr. Tatoyan and Kure Care treat patients in the Los Angeles area, taking the chronic wounds from critical to complete healing utlizing revolutionary regenerative treatments healing wounds 90% faster. These are currently Medicare-covered. Kure Care has doctors available nationwide to treat patients.
Kure Care is a division of Veracor Group LLC, a specialized investment management firm. The company focuses on advanced wound care solutions and is dedicated to providing accessible, effective treatments for individuals with chronic and complex wounds.
Beneficiaries and caregivers should act now and can learn more by visiting the company website at https://curewounds.com.
Contact Info:
Name: Kenton Gray
Email: Send Email
Organization: Kure Care a division of Veracor Group LLC
Address: 1150 NW 72ND AVE TOWER 1 STE 455 #20073 , Miami, FL 33126, United States
Phone: +1-818-858-5551
Website: https://curewounds.com
Release ID: 89172169